1. Home
  2. CAN vs SAGE Comparison

CAN vs SAGE Comparison

Compare CAN & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • SAGE
  • Stock Information
  • Founded
  • CAN 2013
  • SAGE 2010
  • Country
  • CAN Singapore
  • SAGE United States
  • Employees
  • CAN N/A
  • SAGE N/A
  • Industry
  • CAN Semiconductors
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • SAGE Health Care
  • Exchange
  • CAN Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • CAN 384.3M
  • SAGE 415.0M
  • IPO Year
  • CAN 2019
  • SAGE 2014
  • Fundamental
  • Price
  • CAN $0.70
  • SAGE $7.43
  • Analyst Decision
  • CAN Strong Buy
  • SAGE Hold
  • Analyst Count
  • CAN 4
  • SAGE 19
  • Target Price
  • CAN $3.88
  • SAGE $9.88
  • AVG Volume (30 Days)
  • CAN 16.3M
  • SAGE 1.3M
  • Earning Date
  • CAN 05-16-2025
  • SAGE 04-29-2025
  • Dividend Yield
  • CAN N/A
  • SAGE N/A
  • EPS Growth
  • CAN N/A
  • SAGE N/A
  • EPS
  • CAN N/A
  • SAGE N/A
  • Revenue
  • CAN $269,324,000.00
  • SAGE $41,243,000.00
  • Revenue This Year
  • CAN $161.88
  • SAGE $100.39
  • Revenue Next Year
  • CAN $35.55
  • SAGE $70.86
  • P/E Ratio
  • CAN N/A
  • SAGE N/A
  • Revenue Growth
  • CAN 27.35
  • SAGE N/A
  • 52 Week Low
  • CAN $0.65
  • SAGE $4.62
  • 52 Week High
  • CAN $3.27
  • SAGE $15.74
  • Technical
  • Relative Strength Index (RSI)
  • CAN 32.99
  • SAGE 49.65
  • Support Level
  • CAN $0.65
  • SAGE $7.28
  • Resistance Level
  • CAN $0.77
  • SAGE $7.64
  • Average True Range (ATR)
  • CAN 0.07
  • SAGE 0.37
  • MACD
  • CAN 0.01
  • SAGE -0.01
  • Stochastic Oscillator
  • CAN 19.48
  • SAGE 65.57

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: